Guizhou Xinbang Pharmaceutical Co Ltd (002390) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.034x

Based on the latest financial reports, Guizhou Xinbang Pharmaceutical Co Ltd (002390) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥234.19 Million ≈ $34.27 Million USD) by net assets (CN¥6.97 Billion ≈ $1.02 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Guizhou Xinbang Pharmaceutical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Guizhou Xinbang Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Guizhou Xinbang Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 002390 share price today for real-time trading data and today's change.

Guizhou Xinbang Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guizhou Xinbang Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Review 002390 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
BMC Medical Co. Ltd. A SHE:301367	N/A
Shanghai Haohai Biological Tech Co SHG:688366	0.019x
Ningxia Building Materials Group Co Ltd SHG:600449	0.044x
Suzhou Shihua New Material Technology Co Ltd SHG:688093	0.030x
Blacksky Technology Inc NYSE:BKSY	-0.021x
Danya Cebus TA:DNYA	-0.046x
Lithium Argentina AG NYSE:LAR	-0.008x
Bear Electric Appliance Co Ltd SHE:002959	-0.001x

Annual Cash Flow Conversion Efficiency for Guizhou Xinbang Pharmaceutical Co Ltd (2006–2024)

The table below shows the annual cash flow conversion efficiency of Guizhou Xinbang Pharmaceutical Co Ltd from 2006 to 2024. Also see Guizhou Xinbang Pharmaceutical Co Ltd asset portfolio for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥7.02 Billion ≈ $1.03 Billion	CN¥634.97 Million ≈ $92.92 Million	0.090x	-18.29%
2023-12-31	CN¥7.14 Billion ≈ $1.05 Billion	CN¥790.62 Million ≈ $115.69 Million	0.111x	+32.38%
2022-12-31	CN¥7.07 Billion ≈ $1.03 Billion	CN¥590.80 Million ≈ $86.45 Million	0.084x	+24.68%
2021-12-31	CN¥6.83 Billion ≈ $999.22 Million	CN¥457.97 Million ≈ $67.02 Million	0.067x	-53.29%
2020-12-31	CN¥5.17 Billion ≈ $756.31 Million	CN¥742.11 Million ≈ $108.59 Million	0.144x	-18.22%
2019-12-31	CN¥5.05 Billion ≈ $738.73 Million	CN¥886.33 Million ≈ $129.70 Million	0.176x	+515.18%
2018-12-31	CN¥5.17 Billion ≈ $756.32 Million	CN¥-218.56 Million ≈ $-31.98 Million	-0.042x	-241.67%
2017-12-31	CN¥6.76 Billion ≈ $989.00 Million	CN¥201.74 Million ≈ $29.52 Million	0.030x	+197.48%
2016-12-31	CN¥6.49 Billion ≈ $948.96 Million	CN¥-198.59 Million ≈ $-29.06 Million	-0.031x	-137.59%
2015-12-31	CN¥2.67 Billion ≈ $390.56 Million	CN¥217.40 Million ≈ $31.81 Million	0.081x	+200.81%
2014-12-31	CN¥2.46 Billion ≈ $359.67 Million	CN¥-198.60 Million ≈ $-29.06 Million	-0.081x	-292.27%
2013-12-31	CN¥1.04 Billion ≈ $151.59 Million	CN¥-21.34 Million ≈ $-3.12 Million	-0.021x	+42.23%
2012-12-31	CN¥1.02 Billion ≈ $149.64 Million	CN¥-36.46 Million ≈ $-5.34 Million	-0.036x	+12.39%
2011-12-31	CN¥979.53 Million ≈ $143.34 Million	CN¥-39.87 Million ≈ $-5.83 Million	-0.041x	-1661.76%
2010-12-31	CN¥959.70 Million ≈ $140.43 Million	CN¥2.50 Million ≈ $365.97K	0.003x	-98.42%
2009-12-31	CN¥252.83 Million ≈ $37.00 Million	CN¥41.75 Million ≈ $6.11 Million	0.165x	+37.96%
2008-12-31	CN¥207.69 Million ≈ $30.39 Million	CN¥24.86 Million ≈ $3.64 Million	0.120x	-35.86%
2007-12-31	CN¥174.08 Million ≈ $25.47 Million	CN¥32.49 Million ≈ $4.75 Million	0.187x	+266.24%
2006-12-31	CN¥144.17 Million ≈ $21.10 Million	CN¥7.35 Million ≈ $1.07 Million	0.051x	--

About Guizhou Xinbang Pharmaceutical Co Ltd

SHE:002390 China Drug Manufacturers - Specialty & Generic

Market Cap

$856.18 Million

CN¥5.85 Billion CNY

Market Cap Rank

#9574 Global

#2445 in China

Share Price

CN¥3.01

Change (1 day)

+2.38%

52-Week Range

CN¥2.60 - CN¥4.15

All Time High

CN¥14.40